Bayer receives Japanese approval for finerenone to treat patients with chronic heart failure: Berlin Tuesday, December 23, 2025, 14:00 Hrs [IST] Bayer announced that Japan’s Min ...

An ongoing trial at the Medical University of South Carolina is looking for a breakthrough for patients dealing with heart ...

Dr Pradeep highlights warning signs of heart failure, including increased urination at night, swollen ankles, and breathlessness.

Berlin: Bayer has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for finerenone (Kerendia), a ...

A collaboration of researchers in Switzerland, Germany, and the US tracked cardiac function in recreational marathon runners ...

GLP-1s improved outcomes in patients with heart failure with preserved ejection fraction, with or without obesity, but those ...

A cohort study in patients with heart failure (HF) found that dapagliflozin and empagliflozin provided comparable clinical ...

The number of US adults living with heart failure has more than doubled over the past three decades, mostly due to the rising ...

FDA approved CYTK's Myqorzo for oHCM. It reduces heart's pumping ability, has a warning for heart failure and expected to ...

Robot-assisted training with a lightweight exosuit may help patients with advanced heart failure walk more and help them stay ...

"HCM is a heart muscle disease associated with a significant symptom burden. This approval of a new drug, Myqorzo, represents ...

Ultromics, a pioneer in AI-driven cardiology solutions, today announced an investment from the American Heart Association's Go Red for Women Venture Fund, a fund within American Heart Association ...